Pfizer has a market cap of 245 B with a lot of cash and the fund has 1 B cash. It could well be that the offer to get PBT2 (if done) by both of these is on a very different level. Pfizer can do everything that the fund can offer, IMO.
I hope there is this competition and most likely the end of the competition is very close.
Pfizer / Antimicrobial-resistance fund
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.401K | 800.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 77 | 110142186 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 150940914 | 62 |
View Market Depth
| Last trade - 10.20am 08/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |